Heavy lifetime cannabis use is associated with reduced brain activation in key cognitive regions, particularly during working ...

The 12-month open-label extension of the PACIFIC trial demonstrated that bexicaserin significantly reduced seizure frequency ...

Our grey matter has always been a mystery, even to neurologists, but Professor Masud Husain says life-changing advances may ...

A pathway once considered fundamental in Alzheimer’s disease is being studied intensely again, and may soon result in safer, ...

L ong-term heavy cannabis use could have a detrimental effect on an aspect of cognition called working memory, according to ...

Bexicaserin achieved an overall median seizure reduction of 59.3 percent in countable motor seizures over a 12-month open-label extension (OLE) treatment period. The treatment with bexicaserin ...

Recent developments, however, suggest that strategies to treat pain are starting to match its complexity with a new sophistication. The management of chronic pain in general is now being broadly ...

February is observed as American Heart Month, a period dedicated to raising awareness about heart health. The first American Heart ...

A new international study has unveiled critical insights in understanding post-traumatic epilepsy (PTE), a condition that can develop following traumatic brain injury.

What was of particular interest (in relation to the recovery of John Famechon) was the process of discovering what was ...

In a significant advancement for Parkinson’s Disease (PD) therapy, researchers have developed a targeted nano formulation ...